FIELD: biotechnology.
SUBSTANCE: invention describes production of recombinant antigen of porcine circovirus virus 2 (PCV-2) viral capsid and its modification by means of expression in prokaryotic system, purification in monomer form, virus-like particle (VLP) release and use thereof in vaccine compositions, diagnostic kits and a system for quantitative evaluation of PCV-2 antigen in batches of vaccines by analysis with the help of (antigen)capturing ELISA. Antigens and compositions of vaccines can be used in animal immunization programs for controlling PCV-2-associated diseases in conventional pigs breeding systems, and they are alternatives to commercially available vaccines.
EFFECT: kit for ELISA can be used to assess the quality of commercially available and / or experimental PCV-2 vaccines.
11 cl, 16 dwg, 2 ex
Authors
Dates
2019-05-06—Published
2014-01-23—Filed